AHR and cancer: Overall, these findings indicated that HDAC inhibitors impaired the activity of HDAC to impair invasive properties of cancer cells by facilitating an increase in the formation of AhR/HDAC complexes for the inhibition of HDAC activities and stability of histone acetylation patterns.